Cleared Traditional

K142697 - NExCT 7

K142697 is an FDA 510(k) clearance for NExCT 7, manufactured by Neurologica Corporation. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K142697 · Neurologica Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
92d
Days
Class 2
Risk

K142697 is an FDA 510(k) clearance for the NExCT 7. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Neurologica Corporation (Danvers, US). The FDA issued a Cleared decision on December 23, 2014 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurologica Corporation devices

FDA 510(k) Submission Details - K142697

510(k) Number K142697 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2014
Decision Date December 23, 2014
Days to Decision 92 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 107d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 640
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K142697.
Aquilion ONE Vision, v7.0
K142465 · Toshibamedical Systems Corporation · Mar 2015
iMAR
K142584 · Siemens Medical Solutions USA, Inc. · Jan 2015
CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT
K143223 · Toshibamedical Systems Corporation · Jan 2015
CLEARVIEW
K133373 · Neusoft Medical Systems Co., Ltd. · Dec 2014
AQUILION PRIME, V6.00
K141741 · Toshibamedical Systems Corporation · Nov 2014
SYNGO, CT LIVER ANALYSIS
K133643 · Siemens Medi Cal Solutions, Inc. · Nov 2014